{
    "id": "NGN-2026-ICP-DDC-01",
    "type": "dragAndDropCloze",
    "stem": "The nurse is documenting the plan of care for a client with signs of increasing intracranial pressure (ICP). Complete the following sentences by dragging the appropriate options from the list provided.",
    "passage": "1. Administer [blank1] as a first-line osmotic diuretic to reduce cerebral edema and lower intracranial pressure.\n2. Position the client with the head of the bed elevated to [blank2] degrees, ensuring the neck is in a neutral position.\n3. Prevent straining from constipation, which elevates ICP, by administering [blank3] as prescribed.\n4. Continuously monitor [blank4] to calculate and maintain an adequate cerebral perfusion pressure (CPP).\n5. Reduce metabolic demand and cerebral stimulation by minimizing [blank5] and clustering nursing activities.",
    "options": [
        {
            "id": "opt_01",
            "text": "Mannitol"
        },
        {
            "id": "opt_02",
            "text": "30-45"
        },
        {
            "id": "opt_03",
            "text": "Stool Softeners"
        },
        {
            "id": "opt_04",
            "text": "Blood Pressure"
        },
        {
            "id": "opt_05",
            "text": "Loud Noises"
        },
        {
            "id": "opt_06",
            "text": "Furosemide"
        },
        {
            "id": "opt_07",
            "text": "60-90"
        },
        {
            "id": "opt_08",
            "text": "Seizures"
        },
        {
            "id": "opt_09",
            "text": "Hyperventilation"
        }
    ],
    "correctResponse": {
        "blank1": "opt_01",
        "blank2": "opt_02",
        "blank3": "opt_03",
        "blank4": "opt_04",
        "blank5": "opt_05"
    },
    "itemContext": {
        "patient": {
            "age": "72",
            "sex": "Male",
            "pronouns": "He/him",
            "allergies": [
                "No Known Drug Allergies"
            ]
        },
        "tabs": [
            {
                "id": "clinical_feed",
                "title": "Clinical Feed",
                "content": [
                    {
                        "note_type": "Admission Note",
                        "timestamp": "Day 1, 03:00",
                        "text": "S: Client is a 72-year-old male with a history of hypertension and hyperlipidemia, brought in by ambulance after his adult child reported a sudden onset of right-sided weakness and slurred speech. \nB: Initial assessment reveals significant neurological deficits. Client lives alone in a second-floor apartment with no elevator, which delayed emergency services access. He reports financial difficulty in affording his antihypertensive medications, stating he often 'skips doses to make the prescription last longer.' He is a full code. \nA: Primary language is English. Social determinants of health (SDOH) include mobility challenges at home and medication non-adherence due to cost, which are significant barriers to care. \nR: Plan is to stabilize, perform imaging, and consider thrombolytic therapy."
                    },
                    {
                        "note_type": "Progress Note",
                        "timestamp": "Day 1, 07:00",
                        "text": "S: Client's neurological status has declined over the past hour. \nB: Admitted at 03:00 for acute ischemic stroke, received IV alteplase at 03:45. History of hypertension and medication non-adherence. \nA: GCS has dropped from 14 to 12 (E3, V4, M5). Right pupil is now 5mm and sluggishly reactive, compared to the left at 3mm and brisk. Cushing's triad is emerging: BP is 180/100 mmHg, heart rate is 58 bpm, and respiratory rate is 12/min and shallow. Client had one episode of emesis at 06:45. These findings are highly indicative of increasing intracranial pressure (ICP), possibly from cerebral edema or hemorrhagic conversion. \nR: Recommend immediate neurosurgical consult. Prepare for potential ICP monitoring insertion. Administer mannitol as ordered. Maintain strict BP control per protocol to optimize cerebral perfusion pressure. Prepare for urgent repeat head CT."
                    }
                ]
            },
            {
                "id": "vitals_telemetry",
                "title": "Vitals & Telemetry",
                "content": [
                    {
                        "Time": "05:00",
                        "BP (mmHg)": "165/88",
                        "MAP (mmHg)": "114",
                        "HR (bpm)": "65",
                        "RR (/min)": "16",
                        "SpO₂ (%)": "96% on 2L NC",
                        "Temp °F (°C)": "98.6 (37.0)"
                    },
                    {
                        "Time": "06:00",
                        "BP (mmHg)": "170/90",
                        "MAP (mmHg)": "117",
                        "HR (bpm)": "60",
                        "RR (/min)": "14",
                        "SpO₂ (%)": "96% on 2L NC",
                        "Temp °F (°C)": "98.6 (37.0)"
                    },
                    {
                        "Time": "07:00",
                        "BP (mmHg)": "180/100",
                        "MAP (mmHg)": "127",
                        "HR (bpm)": "58",
                        "RR (/min)": "12",
                        "SpO₂ (%)": "95% on 2L NC",
                        "Temp °F (°C)": "98.7 (37.1)"
                    }
                ]
            },
            {
                "id": "lab_diagnostics",
                "title": "Lab Diagnostics",
                "content": [
                    {
                        "Test": "Sodium",
                        "Result": "140",
                        "Unit": "mEq/L",
                        "Reference Range": "136-145",
                        "Status": ""
                    },
                    {
                        "Test": "Potassium",
                        "Result": "4.2",
                        "Unit": "mEq/L",
                        "Reference Range": "3.5-5.0",
                        "Status": ""
                    },
                    {
                        "Test": "Serum Osmolality",
                        "Result": "290",
                        "Unit": "mOsm/kg",
                        "Reference Range": "275-295",
                        "Status": ""
                    },
                    {
                        "Test": "BUN",
                        "Result": "15",
                        "Unit": "mg/dL",
                        "Reference Range": "10-20",
                        "Status": ""
                    },
                    {
                        "Test": "Creatinine",
                        "Result": "1.0",
                        "Unit": "mg/dL",
                        "Reference Range": "0.6-1.2",
                        "Status": ""
                    },
                    {
                        "Test": "Glucose",
                        "Result": "110",
                        "Unit": "mg/dL",
                        "Reference Range": "70-110",
                        "Status": "High"
                    },
                    {
                        "Test": "PT/INR",
                        "Result": "1.1",
                        "Unit": "",
                        "Reference Range": "0.8-1.2",
                        "Status": ""
                    },
                    {
                        "Test": "aPTT",
                        "Result": "30",
                        "Unit": "seconds",
                        "Reference Range": "25-35",
                        "Status": ""
                    }
                ]
            },
            {
                "id": "physical_exam",
                "title": "Physical Exam",
                "content": [
                    {
                        "timestamp": "Day 1, 03:00 (Admission)",
                        "system": "Neurological",
                        "findings": "GCS 14 (E4, V4, M6). Pupils 3mm, equal, round, reactive to light and accommodation. Right-sided hemiparesis (2/5 strength). Facial droop on right. Dysarthria present."
                    },
                    {
                        "timestamp": "Day 1, 07:00 (Focused)",
                        "system": "Neurological",
                        "findings": "GCS 12 (E3, V4, M5). Left pupil 3mm, briskly reactive. Right pupil 5mm, sluggishly reactive to light. Right-sided hemiplegia (0/5 strength). No response to painful stimuli on right side."
                    }
                ]
            },
            {
                "id": "radiology",
                "title": "Radiology",
                "content": [
                    {
                        "type": "CT Head without contrast",
                        "timestamp": "Day 1, 03:15",
                        "report": "FINDINGS: No evidence of acute intracranial hemorrhage. There is subtle loss of gray-white matter differentiation in the left middle cerebral artery (MCA) territory, consistent with early signs of an acute ischemic stroke. No mass effect or midline shift noted at this time.\nIMPRESSION: Acute left MCA territory ischemic stroke. No evidence of hemorrhage, clearing the patient for thrombolytic therapy."
                    }
                ]
            },
            {
                "id": "care_plan",
                "title": "Care Plan",
                "content": [
                    {
                        "Order Date/Time": "Day 1, 03:10",
                        "Action": "Admit to Neuro ICU. Full Code.",
                        "Frequency/Status": "Standing"
                    },
                    {
                        "Order Date/Time": "Day 1, 03:10",
                        "Action": "Neurological checks every 15 minutes.",
                        "Frequency/Status": "Standing"
                    },
                    {
                        "Order Date/Time": "Day 1, 03:10",
                        "Action": "Elevate head of bed 30-45 degrees, maintain neck in neutral alignment.",
                        "Frequency/Status": "Standing"
                    },
                    {
                        "Order Date/Time": "Day 1, 03:10",
                        "Action": "Keep SBP > 140 mmHg and < 185 mmHg post-tPA.",
                        "Frequency/Status": "Standing"
                    },
                    {
                        "Order Date/Time": "Day 1, 07:05",
                        "Action": "Mannitol 1 g/kg IV push over 30 minutes for signs of neurological decline.",
                        "Frequency/Status": "STAT"
                    },
                    {
                        "Order Date/Time": "Day 1, 03:10",
                        "Action": "Docusate Sodium 100 mg PO daily.",
                        "Frequency/Status": "Standing"
                    }
                ]
            },
            {
                "id": "mar_console",
                "title": "MAR Console",
                "content": [
                    {
                        "Medication": "Alteplase (tPA) 81 mg IV",
                        "Dose": "81 mg",
                        "Route": "IV Infusion",
                        "Frequency": "One-time",
                        "Last Administered": "Day 1, 03:45"
                    },
                    {
                        "Medication": "Labetalol",
                        "Dose": "10 mg",
                        "Route": "IV Push",
                        "Frequency": "PRN for SBP > 185 mmHg",
                        "Last Administered": "Not administered"
                    },
                    {
                        "Medication": "Mannitol",
                        "Dose": "1 g/kg",
                        "Route": "IV Push",
                        "Frequency": "STAT",
                        "Last Administered": "Not administered"
                    },
                    {
                        "Medication": "Docusate Sodium",
                        "Dose": "100 mg",
                        "Route": "PO",
                        "Frequency": "Daily",
                        "Last Administered": "Not administered"
                    }
                ]
            }
        ]
    },
    "rationale": {
        "correct": "The correct plan of care for increased intracranial pressure (ICP) focuses on reducing cerebral volume, promoting venous outflow, maintaining cerebral perfusion, and preventing secondary insults. This includes administering an osmotic diuretic (Mannitol), optimizing head positioning (30-45 degrees), preventing Valsalva-inducing activities (constipation), managing blood pressure to ensure adequate CPP, and minimizing environmental stimuli.",
        "incorrect": "Furosemide is a loop diuretic and is less effective than mannitol for rapid reduction of cerebral edema. Elevating the head of the bed to 60-90 degrees is too high and can cause hip flexion, increasing intra-abdominal pressure and impeding venous return, potentially lowering CPP. While preventing seizures is important, it is not the purpose of a stool softener. Hyperventilation is a temporary, last-resort measure for refractory ICP as it can cause cerebral vasoconstriction and ischemia.",
        "answerBreakdown": [
            {
                "optionId": "opt_01",
                "content": "Correct. Mannitol is an osmotic diuretic that creates an osmotic gradient, drawing fluid from the brain parenchyma into the intravascular space to be excreted by the kidneys. This rapidly reduces cerebral edema and ICP. It is the first-line pharmacological agent for this condition."
            },
            {
                "optionId": "opt_02",
                "content": "Correct. Elevating the head of the bed to 30-45 degrees uses gravity to promote venous drainage from the head, which helps lower ICP. Keeping the neck neutral prevents jugular vein compression, which would impede this drainage."
            },
            {
                "optionId": "opt_03",
                "content": "Correct. Stool softeners are administered to prevent constipation and the need to strain (Valsalva maneuver) during defecation. The Valsalva maneuver significantly increases intrathoracic pressure, which impedes cerebral venous outflow and causes a sharp spike in ICP."
            },
            {
                "optionId": "opt_04",
                "content": "Correct. Blood pressure is the primary determinant of Mean Arterial Pressure (MAP). Cerebral Perfusion Pressure (CPP) is calculated as MAP minus ICP. MAP must be maintained within a specific range to ensure adequate blood flow and oxygen delivery to the brain without exacerbating cerebral edema."
            },
            {
                "optionId": "opt_05",
                "content": "Correct. Loud noises, bright lights, and excessive handling act as noxious stimuli that can trigger a stress response, increasing blood pressure, metabolic rate, and ICP. A calm, quiet environment is a key non-pharmacological intervention to maintain stable ICP."
            }
        ],
        "clinicalPearls": [
            "Cushing's Triad (hypertension with a widening pulse pressure, bradycardia, and irregular respirations) is a late and ominous sign of brainstem compression from high ICP, requiring immediate intervention.",
            "When administering mannitol, the nurse must monitor serum osmolality. Values >320 mOsm/kg indicate a high risk for acute kidney injury and cellular dehydration.",
            "Cerebral Perfusion Pressure (CPP) target is typically 60-70 mmHg. CPP is calculated as MAP - ICP. In the absence of an ICP monitor, MAP is used as a surrogate marker for perfusion and is tightly controlled."
        ],
        "questionTrap": "The primary trap is confusing different interventions or their parameters. For example, selecting Furosemide instead of Mannitol, or choosing an incorrect head-of-bed elevation. Another trap is focusing on a potential problem (seizures) over the active, life-threatening process (cerebral edema).",
        "mnemonic": "ICP CARE: I-mmobilize head (neutral position), C-O2 & CO2 management, P-ositioning (HOB 30-45°), C-alm environment, A-ssess neuro status, R-educe pressure (diuretics), E-nsure adequate CPP.",
        "reviewUnits": [
            "Neurological Disorders",
            "Pharmacology: Diuretics",
            "Critical Care Nursing"
        ]
    },
    "scoring": {
        "method": "0/1",
        "maxPoints": 5
    },
    "pedagogy": {
        "bloomLevel": "Applying",
        "cjmmStep": "Generate Solutions",
        "nclexCategory": "Physiological Adaptation"
    },
    "qualityMark": "NGN-2026-HI-FI",
    "healedAt": "2026-02-28T14:18:02.999Z"
}